General ag policy; federal ag research funding; FY2024 USDA funding; ag research infrastructure; extraneous issues as they may arise
Completion/implementation of FY23 appropriations bills; FY2024 budget and appropriations; federal research funding; federal formula funds for land grant and public universities; extraneous issues as they may arise
Implementation of FY2023 NDAA and DoD appropriations bills; FY2024 NDAA and DoD appropriations; defense research funding; UAS and C-UAS research; extraneous issues as they may arise
Pell funding; FY2024 Dept of ED funding programs; other extraneous issues as they may arise
Graduate Medical Education funding; Teaching Health Center GME reauthorization and funding; indigenous health centers; AHEC program; MSE program; other extraneous issues as they may arise
FY2024 federal research funding; implementation of CHIPS and Science Act; NSF programs; research infrastructure funding; research integrity and security; EPSCoR; other extraneous issues as they may arise
Implementing Bipartisan Infrastructure Legislation; DoT research funding; UTC programs; other extraneous issues as they may arise
College Name, Image, and Likeness (NIL); other extraneous issues as they may arise
Graduate Medical Education funding; Teaching Health Center GME reauthorization and funding; physician training and access to rural health care; indigenous health centers; AHEC; MSE program; other extraneous issues as they may arise
International/Foreign students; DACA and related programs; student visa programs and other extraneous issues as they may arise
Duration: October 1, 2020
to
present
May Have Ended?
General Issues: Agriculture , Budget/Appropriations , Defense , Education , Medical/Disease Research/Clinical Labs , Science/Technology , Transportation , Sports/Athletics , Health Issues , Immigration , Aerospace , Aviation/Aircraft/Airlines
Spending: about $485,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2020: U.S. Senate, House of Representatives, Natl Science Foundation (NSF)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Amanda Hill Aide to:Rep Watkins, 7/00-6/02;Sen. Inhofe, 2-8/2003; Sen Collins, 7/06-3/07; Sen. Lankford, 1/15-12/16; HSGAC-RAFM, Maj Staff, 12/16-12/19; Confidential Asst., USTR, 6/02-2/03
Legs Staff to: Rep Wes Watkins, 7/00-06/02; Sen. Inhofe, 02-08/2003; Sen. Collins, 07/06-03/07. Confidential Asst, Ofc of USTR, 06/02-02/03. Field Rep, Sen. Lankford, 1/2015-12/2016. HSGAC-RAFM, Maj Staff, 12/2016-12/2019
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
This representation may have ended. No reports have been filed in the past 160 days, though termination paperwork has not been released.
3rd Quarter, 2023
In Q3, OKLAHOMA STATE UNIVERSITY did no lobbying for itself. The report was filed on Dec. 11, 2023.
Original Filing: 301520413.xml
2nd Quarter, 2023
In Q2, OKLAHOMA STATE UNIVERSITY had in-house lobbyists. The report was filed on July 11, 2023.
Original Filing: 301474540.xml
Lobbying Issues
General ag policy; federal ag research funding; FY2024 USDA funding; ag research infrastructure; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Completion/implementation of FY23 appropriations bills; FY2024 budget and appropriations; federal research funding; federal formula funds for land grant and public universities; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of FY2023 NDAA and DoD appropriations bills; FY2024 NDAA and DoD appropriations; defense research funding; UAS and C-UAS research; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Pell funding; FY2024 Dept of ED funding programs; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Graduate Medical Education funding; Teaching Health Center GME reauthorization and funding; indigenous health centers; AHEC program; MSE program; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FY2024 federal research funding; implementation of CHIPS and Science Act; NSF programs; research infrastructure funding; research integrity and security; EPSCoR; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementing Bipartisan Infrastructure Legislation; DoT research funding; UTC programs; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
College Name, Image, and Likeness (NIL); other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Graduate Medical Education funding; Teaching Health Center GME reauthorization and funding; physician training and access to rural health care; indigenous health centers; AHEC; MSE program; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
International/Foreign students; DACA and related programs; student visa programs and other extraneous issues as they may arise
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2023
In Q1, OKLAHOMA STATE UNIVERSITY had in-house lobbyists. The report was filed on April 20, 2023.
Original Filing: 301459928.xml
Lobbying Issues
General ag policy; federal ag research funding; FY2024 USDA funding; ag research infrastructure; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Completion/implementation of FY23 appropriations bills; FY2024 budget and appropriations; federal research funding; federal formula funds for land grant and public universities; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of FY2023 NDAA and DoD appropriations bills; FY2024 NDAA and DoD appropriations; defense research funding; UAS and C-UAS research; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Pell funding; FY2024 Dept of ED funding programs; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Graduate Medical Education funding; Teaching Health Center GME reauthorization and funding; indigenous health centers; AHEC program; MSE program; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FY2024 federal research funding; implementation of CHIPS and Science Act; NSF programs; research infrastructure funding; research integrity and security; EPSCoR; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementing Bipartisan Infrastructure Legislation; DoT research funding; UTC programs; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
College Name, Image, and Likeness (NIL); other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Graduate Medical Education funding; Teaching Health Center GME reauthorization and funding; physician training and access to rural health care; indigenous health centers; AHEC; MSE program; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
International/Foreign students; DACA and related programs; student visa programs and other extraneous issues as they may arise
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2022
In Q4, OKLAHOMA STATE UNIVERSITY had in-house lobbyists. The report was filed on Jan. 20, 2023.
Original Filing: 301436742.xml
Lobbying Issues
General ag policy; federal ag research funding; FY2023 USDA funding; ag infrastructure; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Completion/implementation of FY22 appropriations bills; FY2023 budget and appropriations; federal research funding; federal formula funds for land grant and public universities; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of FY2022 NDAA and DoD appropriations bills; FY2023 NDAA and DoD appropriations; defense research funding; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Pell funding; FY2023 Dept of ED programs; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Graduate Medical Education funding; Teaching Health Center GME reauthorization and funding; indigenous health center; AHEC program; MSE program; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FY2023 federal research funding; RISE Act; US COMPETES Act; CHIPS and Science Act; NSF reauthorization; research infrastructure funding; research integrity and security; EPSCoR; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementing Bipartisan Infrastructure Legislation; DoT research funding; UTC program; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
College Name, Image, and Likeness (NIL) legislation
Agencies Lobbied
U.S. Senate
Lobbying Issues
Graduate Medical Education funding; Teaching Health Center GME reauthorization and funding; indigenous health center; AHEC; MSE program; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
International/Foreign student issues; DACA and related programs; student visa programs and other extraneous issues as they may arise
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2022
In Q3, OKLAHOMA STATE UNIVERSITY had in-house lobbyists. The report was filed on Oct. 12, 2022.
Original Filing: 301403158.xml
Lobbying Issues
General ag policy; federal ag research funding; FY2023 USDA funding; ag infrastructure; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Completion/implementation of FY22 appropriations bills; FY2023 budget and appropriations; federal research funding; federal formula funds for land grant and public universities; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of FY2022 NDAA and DoD appropriations bills; FY2023 NDAA and DoD appropriations; defense research funding; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Pell funding; FY2023 Dept of ED programs; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Graduate Medical Education funding; Teaching Health Center GME reauthorization and funding; indigenous health center; AHEC program; MSE program; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FY2023 federal research funding; RISE Act; US COMPETES Act; NSF reauthorization; research infrastructure funding; research integrity and security; EPSCoR; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementing Bipartisan Infrastructure Legislation; DoT research funding; UTC program; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
College Name, Image, and Likeness (NIL) legislation
Agencies Lobbied
U.S. Senate
Lobbying Issues
Graduate Medical Education funding; Teaching Health Center GME reauthorization and funding; indigenous health center; AHEC; MSE program; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, OKLAHOMA STATE UNIVERSITY had in-house lobbyists. The report was filed on July 20, 2022.
Original Filing: 301389511.xml
Lobbying Issues
General ag policy; federal ag research funding; FY2023 USDA funding; ag infrastructure; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Completion/implementation of FY22 appropriations bills; FY2023 budget and appropriations; federal research funding; federal formula funds for land grant and public universities; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of FY2022 NDAA and DoD appropriations bills; FY2023 NDAA and DoD appropriations; defense research funding; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Pell funding; FY2023 Dept of ED programs; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Graduate Medical Education funding; Teaching Health Center GME reauthorization and funding; indigenous health center; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FY2023 federal research funding; RISE Act; US COMPETES Act; NSF reauthorization; research infrastructure funding; research integrity and security; EPSCoR; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementing Bipartisan Infrastructure Legislation; DoT research funding; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
College Name, Image, and Likeness (NIL) legislation
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, OKLAHOMA STATE UNIVERSITY had in-house lobbyists. The report was filed on April 20, 2022.
Original Filing: 301368204.xml
Lobbying Issues
General ag policy; federal ag research funding; FY2023 USDA funding; ag infrastructure; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Completion/implementation of FY22 appropriations bills; FY2023 budget and appropriations; federal research funding; federal formula funds for land grant and public universities; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of FY2022 NDAA and DoD appropriations bills; FY2023 NDAA and DoD appropriations; defense research funding; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Pell funding; FY2023 Dept of ED programs; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Graduate Medical Education funding; Teaching Health Center GME reauthorization and funding; indigenous health center; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FY2023 federal research funding; RISE Act; US COMPETES Act; NSF reauthorization; research infrastructure funding; research integrity and security; EPSCoR; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementing Bipartisan Infrastructure Legislation; DoT research funding; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
College Name, Image, and Likeness (NIL) legislation
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, OKLAHOMA STATE UNIVERSITY had in-house lobbyists. The report was filed on Jan. 19, 2022.
Original Filing: 301327514.xml
Lobbying Issues
General ag policy; federal ag research funding; COVID/supplemental ag research funding; ag infrastructure; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of FY21 appropriations bills; FY2022 budget and appropriations; federal research funding; federal formula funds for land grant and public universities; COVID-19 pandemic response; budget reconciliation; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of FY2021 NDAA and DoD appropriations bills; FY2022 NDAA and DoD appropriations; defense research funding; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
COVID-19 emergency response for IHE; Pell funding; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Graduate Medical Education funding; Teaching Health Center GME reauthorization and funding; indigenous health center; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FY2022 federal research funding; COVID-19 emergency research and response; RISE Act; NSF reauthorization; research infrastructure funding; research integrity and security; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
highway/infrastructure legislation and reauthorization; Bipartisan Infrastructure Framework; DoT research funding; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
College Name, Image, and Likeness (NIL) legislation
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, OKLAHOMA STATE UNIVERSITY had in-house lobbyists. The report was filed on Oct. 19, 2021.
Original Filing: 301302936.xml
Lobbying Issues
General ag policy; federal ag research funding; COVID/supplemental ag research funding; ag infrastructure; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of FY21 appropriations bills; FY2022 budget and appropriations; federal research funding; federal formula funds for land grant and public universities; COVID-19 pandemic response; budget reconciliation; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of FY2021 NDAA and DoD appropriations bills; FY2022 NDAA and DoD appropriations; defense research funding; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
COVID-19 emergency response for IHE; Pell funding; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Graduate Medical Education funding; Teaching Health Center GME reauthorization and funding; indigenous health center; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FY2022 federal research funding; COVID-19 emergency research and response; RISE Act; NSF reauthorization; research infrastructure funding; research integrity and security; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
highway/infrastructure legislation and reauthorization; Bipartisan Infrastructure Framework; DoT research funding; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
College Name, Image, and Likeness (NIL) legislation
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, OKLAHOMA STATE UNIVERSITY had in-house lobbyists. The report was filed on July 19, 2021.
Original Filing: 301281961.xml
Lobbying Issues
General ag policy; federal ag research funding; COVID/supplemental ag research funding; ag infrastructure; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of FY21 appropriations bills; FY2022 budget and appropriations; federal research funding; federal formula funds for land grant and public universities; COVID-19 pandemic response legislation; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of FY2021 NDAA and DoD appropriations bills; FY2022 NDAA and DoD appropriations; defense research funding; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
COVID-19 emergency response for IHE; Pell funding; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Graduate Medical Education funding; Teaching Health Center GME reauthorization and funding; indigenous health center; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FY2022 federal research funding; COVID-19 emergency research and response; RISE Act; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
highway/infrastructure legislation and reauthorization; DoT research funding; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
College Name, Image, and Likeness (NIL) legislation
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, OKLAHOMA STATE UNIVERSITY had in-house lobbyists. The report was filed on April 20, 2021.
Original Filing: 301262646.xml
Lobbying Issues
General ag policy; federal ag research funding; COVID/supplemental ag research funding; ag infrastructure; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of FY21 appropriations bills; FY2022 budget and appropriations; federal research funding; federal formula funds for land grant and public universities; COVID-19 pandemic respons legislation; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of FY2021 NDAA and DoD appropriations bills; FY2022 NDAA and DoD appropriations; defense research funding; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
higher ed reauthorization; COVID-19 emergency response for IHE; Pell funding; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
COVID-19 emergency response and international student visa programs; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Graduate Medical Education funding; Teaching Health Center GME reauthorization and funding; indigenous health center; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FY2022 federal research funding; COVID-19 emergency research and response; RISE Act; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
highway/infrastructure legislation and reauthorization; DoT research funding; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
College Name, Image, and Likeness (NIL) legislation
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, OKLAHOMA STATE UNIVERSITY had in-house lobbyists. The report was filed on Jan. 20, 2021.
Original Filing: 301239962.xml
Lobbying Issues
General ag policy; federal ag research funding; COVID/supplemental ag research funding; ag infrastructure; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY2021 budget and appropriations bills; federal research funding; federal formula funds for land grant universities; COVID-19 pandemic response bills; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY2021 National Defense Authorization Act; FY21 DoD Appropriations bills; defense research funding; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Higher education reauthorization; COVID-19 emergency response for higher ed; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
COVID-19 emergency response and travel restrictions; international student visa programs and COVID-19; ICE guidance for international students; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
Graduate Medical Education funding; Teaching Health Center GME reauthorization; FY 21 indigenous health center funding; extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FY21 federal research funding; COVID-19 emergency research funding; RISE Act; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
Lobbying Issues
2020 highway bill and extension; INVEST Act; DoT research funding; other extraneous issues as they may arise
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
OKLAHOMA STATE UNIVERSITY filed a lobbying registration on Nov. 6, 2020 for in-house lobbying efforts, effective Oct. 1, 2020.
Original Filing: 301226215.xml
Issue(s) they said they’d lobby about: General ag policy and research; defense and NDAA; higher education; annual budgets and appropriations; federal research funding; infrastructure/highway bills; international student/scholar programs .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...